Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- Dr. Brian Durie- Myeloma Specialist
Dr. Brian Durie- Myeloma Specialist
Dr. Brian Durie, Myeloma Specialist, set the bar for all other MM specialists. When I was first trying desperately to learn about MM, it was Dr. Durie and the IMF that helped me learn about my incurable blood cancer. Since Dr. Durie spent more than an hour talking to me on the phone initially, I assumed that all oncologists would take the time to speak with their patients…
I’ve placed many of Dr. Durie’s videos in my blog posts on various topics on PeopleBeatingCancer.org because Dr. Durie does a great job explaining complex issues. Plus, I think his Scottish accent gives a much-needed boost to a difficult subject.
Dr. Durie on the Black Swan Research Initiative® and a Paradigm Shift in the Treatment of MM
Dr. Durie, you will be missed.
Thank you,
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
The Global Myeloma Community Mourns the Passing of IMF Co-Founder Dr. Brian G.M. Durie
LOS ANGELES, October 14, 2025 — It is with great sadness that the International Myeloma Foundation (IMF) shares the news of the death of Dr. Brian G.M. Durie, co-founder of the organization.
Dr. Durie was a visionary in the field of myeloma, a type of blood cancer that affects plasma cells. His 1975 pioneering work, the Durie-Salmon Staging System, shed light on the myeloma tumor burden and how it impacts other cellular functions. A prolific researcher, Dr. Durie authored over 700 research papers and, up until his death on October 12 at age 82, was energetically engaged in myeloma research projects around the world.
He was passionate about sharing the latest treatment options and guidance with thousands of myeloma patients, many of whom lacked convenient access to state-of-the-art medical information. He stressed the importance of treating the individual, not just the disease, and made lifetime friends of patients around the world. For decades, Dr. Durie served as an inspiring mentor for new generations of myeloma researchers.
In 1990, Dr. Durie, along with Susie Novis Durie and Brian Novis, co-founded the IMF — the first patient advocacy organization dedicated exclusively to multiple myeloma. The organization created a global network of myeloma patient support groups, as well as the International Myeloma Working Group® (IMWG), whose hundreds of myeloma experts conduct collaborative research and publish disease-treatment guidelines for physicians.
To accelerate a cure for the disease, Dr. Durie established the IMF Black Swan Research Initiative® (BSRI) in 2012. Most recently, he collaborated with researchers from the University of Iceland, led by Dr. Sigurdur Kristinsson, on the groundbreaking iStopMM® (Iceland Screens, Treats, or Prevents Multiple Myeloma) Project, which investigates the earliest signs of disease using the country’s deep reserve of genetic data.
“Dr. Durie was a giant in the field like no other. He leaves behind a legacy that will endure forever — from his incredible contributions to myeloma research to the superb care and counseling he provided patients; from educating almost all practicing myeloma experts today to helping advance patient care through important clinical trials; from developing the Durie-Salmon Staging System to co-founding the IMF, a patient-centered organization, which he led for three decades. He had an enormous impact — not just on myeloma but on all of oncology. I have lost a dear friend and mentor and will forever cherish his kindness,” said IMF Chairperson of the Board S. Vincent Rajkumar, MD (Mayo Clinic — Rochester, MN).
“I am deeply saddened by the passing of Dr. Brian G.M. Durie, whose groundbreaking research and unwavering dedication transformed the understanding and treatment of multiple myeloma. His leadership, compassion, and vision profoundly inspired all of us, who had the privilege to know and work alongside him, and shape the global myeloma community. His legacy will live on, through the countless lives he touched and the advances he made for patients worldwide,” said IMF Scientific Advisory Board Member Nikhil Munshi, MD (Dana-Farber Cancer Institute — Boston, MA). Along with Dr. Durie, Dr. Munshi led the i2TEAMM (International Independent Team for Endpoint Approval of Myeloma MRD) to secure regulatory approval for minimal residual disease (MRD) testing for myeloma.
Paul G. Richardson, MD (Dana-Farber Cancer Institute — Boston, MA) recounted the years that he worked with Dr. Durie on different endeavors to improve outcomes for the global myeloma community.
“I was so very sorry to hear of Brian’s unexpected and sudden passing over the weekend. I had the privilege of being with him at an academic meeting in Rome the week before, with other myeloma experts. We enjoyed two very informative and productive days together. His worldwide contributions to research and care were, above all, patient focused. Brian’s foundational role at the IMF reflected this as a central part of his vision along with his wife Susie and their great team.”
“Having worked with him in numerous different ways over many years — from patient seminars, to independent response committees for pivotal clinical trials that led to new drug approvals; and as part of working groups across different key niche areas to improve patient outcomes, including with the FDA — I was always inspired with the way Brian exemplified putting the patient first. On a personal level, he was kind and humorous as well as generous and wise. He will be enormously missed, but his legacy will undoubtedly continue.”
If you wish to reach out to the family, please contact Annabel Reardon at annabelreardon@outlook.com.
Dr. Brian Durie Myeloma Specialist Dr. Brian Durie Myeloma Specialist Dr. Brian Durie Myeloma Specialist